KR20160130780A - Methods for diagnosing and treating inflammatory

Von einem Mystery-Man-Autor
Last updated 16 Juni 2024
KR20160130780A - Methods for diagnosing and treating inflammatory
Official gazette of the unexamined patents
KR20160130780A - Methods for diagnosing and treating inflammatory
KR20160130780A - Methods for diagnosing and treating inflammatory bowel disease - Google Patents
KR20160130780A - Methods for diagnosing and treating inflammatory
Technology Insight: tools for research, diagnosis and clinical assessment of treatment in idiopathic inflammatory myopathies
KR20160130780A - Methods for diagnosing and treating inflammatory
Diagnosis and early management of inflammatory arthritis
KR20160130780A - Methods for diagnosing and treating inflammatory
JCM, Free Full-Text
KR20160130780A - Methods for diagnosing and treating inflammatory
Treatment Patterns and Sequencing in Patients With Inflammatory Bowel Disease - ScienceDirect
KR20160130780A - Methods for diagnosing and treating inflammatory
Inflammation and Inflammatory Diseases, Markers, and Mediators: Role of CRP in Some Inflammatory Diseases
KR20160130780A - Methods for diagnosing and treating inflammatory
Critical Role of histone deacetylase 3 in the regulation of kidney inflammation and fibrosis. - ScienceDirect
KR20160130780A - Methods for diagnosing and treating inflammatory
The Clinical Response of Upadacitinib and Risankizumab is Associated with Reduced Inflammatory Bowel Disease Anti-TNFα Inadequate Response Mechanisms
KR20160130780A - Methods for diagnosing and treating inflammatory
Treat to target versus standard of care for patients with Crohn's disease treated with ustekinumab (STARDUST): an open-label, multicentre, randomised phase 3b trial - The Lancet Gastroenterology & Hepatology
KR20160130780A - Methods for diagnosing and treating inflammatory
KR20160130780A - Methods for diagnosing and treating inflammatory bowel disease - Google Patents
KR20160130780A - Methods for diagnosing and treating inflammatory
Recent advances in inflammatory bowel disease therapy - ScienceDirect

© 2014-2024 fenasera.org.br. Inc. or its affiliates.